Literature DB >> 20484366

Epidemiology and survival of the five stages of chronic kidney disease in a systolic heart failure population.

Kathy Hebert1, Andre Dias, Maria Carolina Delgado, Emiliana Franco, Leonardo Tamariz, Dylan Steen, Patrick Trahan, Brittny Major, Lee M Arcement.   

Abstract

AIMS: The epidemiology of the five stages of chronic kidney disease (CKD) in systolic heart failure (HF) patients has predominantly been described in hospitalized White patients, with little known about the prevalence in outpatient Blacks and Hispanics. The purpose of this study was to compare the prevalence of the five stages of CKD by race, ethnicity (Whites, Blacks, and Hispanics), and gender in an outpatient systolic HF population and also to evaluate the impact of CKD on mortality. METHODS AND
RESULTS: We conducted a prospective study of 1301 patients recruited from two hospital facilities in Louisiana and Florida, USA. All patients were enrolled in a systolic HF disease management programme (HFDMP), which enrolled patients with an ejection fraction of < or =40% by echocardiography. The estimated glomerular filtration rate was calculated using the abbreviated Modification of Diet in Renal Disease Study equation. Patients were classified into five stages of CKD according to the National Kidney Foundation classification system. A total of 338 patients (26%) were found to have CKD. Patients with CKD were older, more likely to be Hispanics, to have less education, New York Heart Association class III, elevated systolic blood pressure, and diabetes. There was no statistical difference in prevalence by gender. Survival was reduced in patients with CKD.
CONCLUSION: The prevalence of CKD in an outpatient systolic HFDMP is high, with over one in four patients affected. CKD patients had significantly lower survival rates compared with patients without CKD.

Entities:  

Mesh:

Year:  2010        PMID: 20484366     DOI: 10.1093/eurjhf/hfq077

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  23 in total

1.  Association between chronic kidney disease progression and cardiovascular disease: results from the CRIC Study.

Authors:  Mahboob Rahman; Dawei Xie; Harold I Feldman; Alan S Go; Jiang He; John W Kusek; James Lash; Edgar R Miller; Akinlolu Ojo; Qiang Pan; Stephen L Seliger; Susan Steigerwalt; Ray R Townsend
Journal:  Am J Nephrol       Date:  2014-11-11       Impact factor: 3.754

2.  Influence of renal dysfunction phenotype on mortality in the setting of cardiac dysfunction: analysis of three randomized controlled trials.

Authors:  Jeffrey M Testani; Steven G Coca; Richard P Shannon; Stephen E Kimmel; Thomas P Cappola
Journal:  Eur J Heart Fail       Date:  2011-09-15       Impact factor: 15.534

Review 3.  Epidemiology and outcome of the cardio-renal syndrome.

Authors:  Dinna N Cruz; Mihai Gheorghiade; Alberto Palazzuoli; Alberto Palazuolli; Claudio Ronco; Sean M Bagshaw
Journal:  Heart Fail Rev       Date:  2011-11       Impact factor: 4.214

Review 4.  The acute cardiorenal syndrome: burden and mechanisms of disease.

Authors:  Petra Nijst; Wilfried Mullens
Journal:  Curr Heart Fail Rep       Date:  2014-12

5.  The Role of Congestion in Cardiorenal Syndrome Type 2: New Pathophysiological Insights into an Experimental Model of Heart Failure.

Authors:  Annalisa Angelini; Chiara Castellani; Grazia Maria Virzì; Marny Fedrigo; Gaetano Thiene; Marialuisa Valente; Claudio Ronco; Giorgio Vescovo
Journal:  Cardiorenal Med       Date:  2015-10-31       Impact factor: 2.041

Review 6.  The treatment gap in patients with chronic systolic heart failure: a systematic review of evidence-based prescribing in practice.

Authors:  Ken Lee Chin; Marina Skiba; Andrew Tonkin; Christopher M Reid; Danny Liew; Henry Krum; Ingrid Hopper
Journal:  Heart Fail Rev       Date:  2016-11       Impact factor: 4.214

7.  Novel urinary tubular injury markers reveal an evidence of underlying kidney injury in children with reduced left ventricular systolic function: a pilot study.

Authors:  Ahmad Kaddourah; Stuart L Goldstein; Rajit Basu; Edwards J Nehus; Tara C Terrell; Lori Brunner; Michael R Bennett; Christopher Haffner; John L Jefferies
Journal:  Pediatr Nephrol       Date:  2016-05-02       Impact factor: 3.714

8.  Prevalence, predictors, and outcomes of cardiorenal syndrome in children with dilated cardiomyopathy: a report from the Pediatric Cardiomyopathy Registry.

Authors:  Ahmad Kaddourah; Stuart L Goldstein; Steven E Lipshultz; James D Wilkinson; Lynn A Sleeper; Minmin Lu; Steven D Colan; Jeffrey A Towbin; Scott I Aydin; Joseph Rossano; Melanie D Everitt; Jeffrey G Gossett; Paolo Rusconi; Paul F Kantor; Rakesh K Singh; John L Jefferies
Journal:  Pediatr Nephrol       Date:  2015-07-26       Impact factor: 3.714

Review 9.  Cardiorenal Syndrome in Western Countries: Epidemiology, Diagnosis and Management Approaches.

Authors:  Claudio Ronco; Luca Di Lullo
Journal:  Kidney Dis (Basel)       Date:  2016-09-10

10.  Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making-a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society.

Authors:  Giuseppe Boriani; Irina Savelieva; Gheorghe-Andrei Dan; Jean Claude Deharo; Charles Ferro; Carsten W Israel; Deirdre A Lane; Gaetano La Manna; Joseph Morton; Angel Moya Mitjans; Marc A Vos; Mintu P Turakhia; Gregory Y H Lip
Journal:  Europace       Date:  2015-06-24       Impact factor: 5.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.